ArticleJournal for immunotherapy of cancer2025

Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity.

Haiyang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.